icon-circle-smiley-face

News Links

Popular Press News for February 9, 2022

Insulin prices are so high in the US it’s forcing families to relocate to afford this life-saving drug As insulin prices soar, some patients ration their doses: ‘You try to make do’ Is Type 1 Diabetes Genetic?

Read More

Daily Care News for February 9, 2022

100,000 Diabetes Deaths; Light’s Effect on Blood Sugar; Wegovy Supply Woes Continue Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 Diabetes kills 100 000 Americans for second year in a row Genetic Risk Score for Coronary Disease in People With Type 1 Diabetes The Relationship Between Depression, Distress, and Diabetes A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes Patient and family perspectives of a Pre-Transition Visit in a paediatric tertiary care diabetes clinic First year on commercial hybrid closed-loop system-experience on 111 […]

Read More

Legislative and Policy News for February 9, 2022

Novo Nordisk challenges House report it collaborated with competitors on insulin prices

Read More

Press Releases and Product Information February 9, 2022

Important Discoveries in Diabetes Highlighted in American Diabetes Association 2021 Research Report UNICEF and Lilly Collaborate to Help Improve Health Outcomes for 10 Million Children and Adolescents With FDA clearance ‘imminent’ for Senseonics 180-day CGM, what’s next? Dexcom G6 now on NDSS. Dexcom G5 being retired!

Read More

Daily Care News for February 2, 2022

Artificial pancreas credited with transforming lives of children with diabetes Type 1 Diabetes Problems Greater With Family History of Type 2 Diabetes FDA clears first tubeless hybrid closed-loop insulin delivery system People with type 1 diabetes report preference for in-person visits to resume post-pandemic Altered Taste Function in Young Individuals With Type 1 Diabetes (Full text HTML, PDF) Vestibular function for children with insulin dependent diabetes using cervical vestibular evoked myogenic potentials testing Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care (Full text HTML, PDF) Brief Assessment of […]

Read More

Press Releases and Product Information February 2, 2022

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control How Bigfoot Biomedical plans to take diabetes management forward Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA Federal Court Rules Children with Diabetes in NYC Denied Equal Access to Field Trips and Bus Transportation Glooko Acquires Germany-Based xbird, a Medical AI Company

Read More

Popular Press News for February 2, 2022

Racial Health Disparities Present in Diabetic Patient Care Access I Write About America’s Absurd Health Care System. Then I Got Caught Up in It. Technology, unexpected study findings redefine diabetes management over 20 years

Read More

Celiac News for February 2, 2022

Does Celiac Disease Run in Families? Systematic Approach to Celiac Disease: A Comprehensive Review for Primary Providers Association between idiopathic pulmonary hemosiderosis and celiac disease in pediatric patients: A scoping review of the literature over the past 50 years Optical coherence tomography angiography findings of retinal vascular structures in children with celiac disease

Read More

Social Media Links for February 2, 2022

Omnipod 5: First Tubeless Automated Insulin Delivery System with Smartphone Control #SpareARose 2022: same, but different Bringing us along for the research ride An invitation to participate in a WHO key informant survey for people with lived experience of diabetes to improve messaging and communication Inside the Drug Pricing Investigation from the House Oversight and Reform Committee Diabetes Online in January 2022: Wordle, Insulin History, New Podcasts, and More ‘Noninvasive’ Glucose Monitoring for Diabetes: Where Is It Now? Is COVID Causing Type 1 Diabetes? Android APS 3.0.0

Read More

Research News for February 2, 2022

Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial) Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes (Full text HTML, PDF) Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes (Full text HTML, PDF) In-depth analysis of proteomic and genomic fluctuations during the time course of human embryonic stem cells directed differentiation into beta cells Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical […]

Read More